The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Congress Approves Six-Month “Doc Fix”—Now What?

Congress Approves Six-Month “Doc Fix”—Now What?

September 1, 2010 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Congress’ May 24 vote to rescind the 21% Medicare pay cut for six months illustrates how important it is for rheumatology professionals and patients to be involved in the legislative process. It was the thousands of calls, e-mails, and letters from medical professionals and patients that spurred Congress to take action. However, the battle is not yet over. Medicare physician payments face the same 21% cut beginning December 1.

You Might Also Like
  • The ACR’s Advocates for Arthritis Volunteers Meet with Congress
  • ACR Talks to Congress about Physician Payment Reform
  • The ACR’s Advocates for Arthritis 2016 Legislative Fly-In Heads to Capitol Hill
Explore This Issue
September 2010
Also By This Author
  • The ACR 2015 State-of-the-Art Clinical Symposium Scheduled May 1–3 in Chicago

We must keep the momentum going. The ACR will be back on Capitol Hill September 21 to advocate for a permanent fix to the Sustainable Growth Rate, but it will take the voice of all rheumatology professionals and patients to get Congress to act. How can you help strengthen the ACR’s message in Washington?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  • Write, call, or e-mail your legislators. As a constituent, your members of Congress are elected to represent you. Contact them frequently to let them know how you feel about important issues.
  • Schedule a meeting with your members of Congress in Washington. Visiting your legislators in Washington, D.C., helps build a relationship and shows that you are a committed advocate.
  • Get your patients involved—they are constituents, too. Encourage them to call or write their members of Congress.

How can you be an effective advocate when members of Congress are at home?

  • Invite your legislators to your office. This is a great opportunity to educate members of Congress on the importance of the rheumatology subspecialty and the effect that arthritis and rheumatic conditions have on quality of life.
  • Meet with your legislators in their district office. An in-person meeting is an effective way to convey your message and allows you to build relationships with your legislators.
  • Volunteer for a campaign. Volunteering is a great way to get involved in the political process. Support the candidate who will best represent the rheumatology community.

We must stay united to effect change. Contact your elected officials and make your voice heard. To find your legislators’ contact information or for more information on ACR advocacy activities, contact advocacy@rheumatology.org, or visit www.rheumatology.org/advocacy.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Filed Under: From the College, Legislation & Advocacy, Professional Topics Tagged With: AC&R, Advocating With You, Billing, Centers for Medicare and Medicaid Services, CMS, Congress, Medicare, Sustainable Growth RateIssue: September 2010

You Might Also Like:
  • The ACR’s Advocates for Arthritis Volunteers Meet with Congress
  • ACR Talks to Congress about Physician Payment Reform
  • The ACR’s Advocates for Arthritis 2016 Legislative Fly-In Heads to Capitol Hill
  • Participate in Virtual Capitol Hill Meetings with the ACR

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.